Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system

Blood

Volumn 88, Issue 3, 1996, Pages 1013-1018

  Dupriez, Brigitte ^a   Morel, Pierre ^b   Demory, Jean L ^b   Lai, Jean L ^b   Simon, Marc ^b   Plantier, Isabelle ^b   Bauters, Francis ^b  

^a Centre Hospitalier de LENS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CANCER SURVIVAL; CYTOGENETICS; FEMALE; HEPATOMEGALY; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; THROMBOCYTOPENIA; WEIGHT REDUCTION;

EID: 0029767865     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.1013.bloodjournal8831013     Document Type: Article

References (21)

1. Barosi G, Berzuini C, Liberato LN, Costa A, Polino G, Ascari E: A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 70:397, 1988
2. Thiele J, Kvasnicka HM, Steinberg T, Zankovich R, Fischer R, Diehl V: Survival in primary (idiopathic) osteomyelofibrosis, socalled agnogenic myeloid metaplasia. Leuk Lymph 6:389, 1992
3. Visani G, Finelli C, Castelli U, Petti MC, Ricci N, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R, Pileri S, Magrini U, Gugliota L, Morra E, Bernasconi C, Mandelli F, Tura S: Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 75:4, 1990
4. Varki A, Lottenberg R, Griffith R, Reinhard E: The syndrome of idiopathic myelofibrosis. A clinico-pathologic review with emphasis on the prognostic variables predicting survival. Medicine 62:353, 1983
5. Njoku OS, Lewis SM, Catovski D, Gordon-Smith EC: Anaemia in myelofibrosis: Its value in prognosis. Br J Haematol 54:79, 1983
6. Demory JL, Dupriez B, Fenaux P, Laï JL, Beuscart R, Jouet JP, Deminatti M, Bauters F: Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases. Blood 72:855, 1988
7. Dupriez B, Demory JL, Laï JL, Fenaux P, Bauters F, Barosi G: Prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 73:136, 1989 (letter)
8. Laszlo J: Myeloproliferative disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocytemia. Semin Hematol 4:409, 1975
9. Bearman RM, Pangalis GA, Rappaport H: Acute ("malignant") myelosclerosis. Cancer 43:279, 1979
10. Chelloul N, Brière J, Laval-Jeantet M, Najean Y, Vorhauer W, Jacquillat C: Prognostic of myeloid metaplasia with myelofibrosis. Biomedicine 24:272, 1976
11. ISCN: An international system for human cytogenetic nomenclature. Cytogenet Cell Genet 21:309, 1978
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
13. Cox DR: Regression models and lifetables (with discussion). JR Stat Soc 34:187, 1972
14. Pereira A, Bruggera M, Cervantes F, Rozman C: Liver involvement at diagnosis of primary myelofibrosis. A clinicopathological study of twenty-two cases. Eur J Haematol 40:355, 1988
15. Najean Y, Cacchione R, Castro Malaspina H, Dresch C: Erythrokinetic studies in myelofibrosis: Their significance for prognosis. Br J Haematol 40:205, 1978
16. Barosi G, Cazzola M, Frassoni F, Orlandi E, Stefanelli M: Erythropoiesis in myelofibrosis with myeloid metaplasia: Recognition of different classes of patients by erythrokinetics. Br J Haematol 48:263, 1981
17. Wang JC, Wang A: Plasma soluble interleukin-2 receptor in patients with primary myelofibrosis. Br J Haematol 86:380, 1994
18. Besa EC, Nowell PC, Geller NL, Gardner FM: Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia. The value of chromosomal studies in predicting response and survival. Cancer 49:308, 1982
19. Reilly JT, Wilson G, Barnett D, Watmore A, Potter A: Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol 88:575, 1994
20. Barosi G, Ambrosetti A, Buratti A, Finelli C, Liberato NL, Quaglini S, Ricetti MM, Visani G, Tura S, Ascari E: Splenectomy for patients with myelofibrosis with myeloid metaplasia: Pretreatment variables and outcome prediction. Leukemia 7:200, 1993
21. Breslow NE, Day NE: The standardized mortality ratio, in Sen PK Biostatistics (eds): Statistics in Biomedical, Public Health and Environmental Sciences. New York, NY, North-Holland/Elsevier Science Publishers BV, 1985, p 55